New Enterprise Associates 16 L.P. 13D and 13G filings for Marker Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-23 4:30 pm Purchase | 2024-12-19 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 1,625,678 15.200% | 554,250 (+51.73%) | Filing |
| 2024-05-17 6:25 pm Purchase | 2024-05-15 | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 1,071,428 12.000% | 1,071,428 (New Position) | Filing |